Working medical devices are essential to #NewbornCare. A peer-reviewed #NEST360 study across Kenya, Malawi, Nigeria & Tanzania found median biomedical workshop readiness rose from 28% to 50%. But spare parts & after-hours staffing remain major gaps.
Read: https://t.co/EMem7x8ouf
Yay‼️ Bloom has a new U.S. patent, further strengthening our IP portfolio supporting next-gen automated ultrasound and AI-enabled EVA™ platform and RAPIDscan™ system. Patents are more than milestones—they help expand imaging access for mothers, babies and children globally.
Stanford researchers scanned teenagers listening to their mothers, having already shown that in young children her voice lights up half the brain. Something had switched.
In children under about twelve, the reward circuitry fires harder for their mother's voice than for a stranger's. In adolescents it flips. The reward regions respond more strongly to unfamiliar voices, and her voice stops being the sound the system reaches for.
The crossover happens somewhere between thirteen and fourteen. Nothing has gone wrong. The circuitry has not broken and she has not been demoted. It is being retuned deliberately, because a person who is going to leave home needs to start finding other people interesting, and the brain arranges that by making everyone outside the house more rewarding to listen to.
Which means the thing every mother of a teenager describes has a mechanism. He is not ignoring her out of contempt. Her voice is no longer arriving at the part of him that used to light up for it.
Two things worth holding onto here. The first is that the hearing and processing regions are still there and still working. He hears her perfectly. What changed is what his reward system does with the sound.
The second is that this is temporary, and there is a whole literature on adult children and their mothers to say so. The circuitry is being repointed outward for the years he needs to build a life away from her. It is not being deleted.
So a woman finds herself talking to somebody who used to run toward her voice across a car park, and who now barely registers it. That is her son's brain doing exactly what it is supposed to do, on schedule, and it is a horrible thing to be on the receiving end of.
https://t.co/WLvIZQm2l3
Don't miss important series on emergency respiratory care with big focus on #oxygen in lead up to #AfCEM2026 9-13 Nov, Tanzania 🇹🇿
Register now for #1 on 26 Aug 👉https://t.co/s9AlwbQ1KM
Kudos @afemafrica & @fphcare!
#GO2AL#InvestinOxygen
Behind every investment is a mission worth believing in. 💡
Congratulations to Annamarie Saarinen and the @BloomStandard team. We're honored to be part of your journey and can't wait to see the impact Bloom Standard continues to make. 🚀
#100InTheGroove
Our latest blog takes a look inside year two of the Minnesota Women’s Investment Collective, recapping the learning, pitches, decisions, and investments that shaped this year’s cohort.
Read the full recap here: https://t.co/BIGoWEUEEX
Founder mistake: board meetings become status updates. Send the deck early, require everyone reads it, then spend the time tackling the 1-3 biggest questions facing the business.
“Something about Swansea felt right, and the resources and collaboration has been there for us from day one.” 💬 Annamarie Saarinen, CEO and Co-founder of @BloomStandard
🔗https://t.co/p231ahSsWy
#WalesInvested#LifeSciences
For those celebrating today, and to the many families and care teams spending today with little ones in medical settings, happy #Thanksgiving. Swift healing and love to you and yours. ❤️🍁 #BloomStandard
How do you decide exactly where the treatment threshold should be?
Dr. Alex Kemper — lead author of the 2022 AAP Hyperbilirubinemia Guidelines — explains why determining phototherapy thresholds took years of debate, evidence review, and committee discussion.
With babies of different gestational ages, varying risk factors, and complex neurotoxicity considerations, there’s no single formula that solves it. Guideline writing meant balancing imperfect data, diverse perspectives, and the goal of protecting infants while avoiding unnecessary treatment.
This conversation is part of our series Rethinking Phototherapy.
→ Watch or listen to the full series on Apple Podcasts, Spotify, or at https://t.co/2RoUquVoPW
.
If you’re passionate about thinking differently in neonatology and advancing innovation in our field, join us for Delphi this January in Florida. Learn more or register at https://t.co/5iywNIJQIU
.
(Rethinking Phototherapy is made possible thanks to support from GE Healthcare.)
Today at @LUTHofficial, we celebrated #WorldPrematurityDay with two sets of thriving 4-year-old quadruplets born here using #NEST360 equipment, & two sets of preterm babies currently in care. 💜
Every baby, no matter how small, deserves a fighting chance. #WPD2025#NewbornCare
“I’ve had the privilege to work in some amazing innovation ecosystems - Medical Alley in Minneapolis, in the Asia-Pacific region and in Europe. But Wales is a really special place. I’ve really not seen anything like it”. 💬@BloomStandard
🔗https://t.co/p231ahSsWy
#WalesInvested
In Silicon Valley last week, with a couple hundred amazing medtech colleagues for #MedTechInnovator#Summit. Bloom was honored to be there as alumni - and to our pediatric ultrasound system in the spotlight! ❤️👏
Our co-founder @asaarinen was the leading advocate in getting #CCHD screening added to the RUSP in the U.S. An amazing legacy that has saved thousands of lives in the years since her baby daughter’s diagnosis with asymptomatic heart defects. 🫀
Pulse oximetry screening for critical congenital heart disease (CCHD) in newborns has decreased early infant deaths by 33%—a landmark improvement in newborn care. This simple, painless test helps neonatologists catch serious heart defects before babies leave the hospital. Learn more about the impact and latest updates on newborn screening by listening to this episode: https://t.co/PsUNq8WjGx.
Pulse oximetry screening for critical congenital heart disease (CCHD) in newborns has decreased early infant deaths by 33%—a landmark improvement in newborn care. This simple, painless test helps neonatologists catch serious heart defects before babies leave the hospital. Learn more about the impact and latest updates on newborn screening by listening to this episode: https://t.co/PsUNq8WjGx.
It’s been an important week for those impacted by CHD! For Bloom Standard, it’s year round, 24/7. Our founders are heart parents, driven. ❤️🩹 A privilege to be working every day to improve the lives of ALL children with congenital and pediatric heart diseases! #CHDawarenessweek
Happy Holidays! To all our partners, collaborators and supporters around the globe, thank you for all you do for vulnerable patients around the world. Here’s to all that 2024 delivered…and to peace, hope and joy in 2025.